share_log

Galectin Therapeutics | 8-K: Galectin Therapeutics Reports Financial Results for the Quarter Ended June 30, 2024 and Provides Business Update

SEC ·  Aug 13 07:57
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more